Author

J. S. L. Yu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Assay:ChIP-seq· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:metabolomics· 1 Organism:yeast· 1

Frequent Co-Authors

A. Freiwald· 1 shared A. Zelezniak· 1 shared B. J. P. Huntly· 1 shared B. Papp· 1 shared C. B. Messner· 1 shared C. Correia-Melo· 1 shared E. De Braekeleer· 1 shared G. S. Vassiliou· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. Freiwald

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistrybioRxivMar 7, 2022

Cell-cell metabolite exchange creates a pro-survival metabolic environment that extends lifespan

C. Correia-Melo, S. Kamrad, C. B. Messner…·M. Ralser

The paper shows that metabolite exchange between cells extends lifespan in yeast by creating a pro-survival metabolic environment.

DOI 10.1016/j.cell.2022.12.007

yeastmetabolomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 25, 2020

KAT7 is a therapeutic vulnerability of MLL-rearranged acute myeloid leukemia

Y. Z. Au, M. Gu, E. De Braekeleer…·K. Yusa

This study identifies KAT7 as a critical therapeutic target in MLL-rearranged AML by showing its role in maintaining acetylation marks and supporting cell proliferation.

DOI 10.1101/2020.04.25.054049

𝕏 PostBluesky